Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor

Kyriakos Neofytou,Elizabeth C. Smyth,Alexandros Giakoustidis,Aamir Z. Khan,David Cunningham,Satvinder Mudan

DOI: https://doi.org/10.1007/s12032-014-0239-6

2014-09-14

Medical Oncology

Abstract:Recent evidence indicates that inflammation is an essential component of pathogenesis and progression of cancer. In this study, we analysed two indexes of systemic inflammation, the neutrophil–lymphocyte ratio (NLR) and platelet—lymphocyte ratio (PLR), with disease-free survival (DFS) and overall survival (OS) in liver-only colorectal metastases treated with liver resection following neoadjuvant chemotherapy. In this retrospective study, 140 patients were enroled. The NLR and PLR were calculated on the basis of preoperative blood cell count, and their cut-off levels were determined by applying receiver operating curve analysis. A NLR >2.4 and a PLR >150 were considered to be elevated. DFS and OS were calculated using both Kaplan–Meier and multivariate Cox regression methods. Both high NLR and high PLR were associated with decreased DFS [HR 1.55; 95 % confidence interval (CI) 1.03–2.32; P = 0.033, and HR 1.78; 95 % CI 1.19–2.67; P = 0.005, respectively] and OS (HR 2.21; 95 % CI 1.24–3.96; P = 0.007, and HR 2.90; 95 % CI 1.61–5.21; P < 0.001, respectively) in univariate analysis, but only PLR remained significant in multivariate analysis for both DFS and OS (HR 1.68; 95 % CI 1.04–2.71; P = 0.034, and HR 2.17; 95 % CI 1.09–4.32; P = 0.027, respectively). When we divided patients into three groups (group 1: normal both NLR and PLR; group 2: high NLR or high PLR; group 3: high both NLR and PLR), the five-year DFS and OS rates for these groups were 43, 26, 9 % (P = 0.004) and 73, 59, 34 % (P < 0.001), respectively. In this study, we indicate that preoperative PLR is superior to preoperative NLR as an adverse prognostic factor in patients who undergo liver resection for liver-only colorectal metastases.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to determine whether the platelet - to - lymphocyte ratio (PLR) can be used as a poor prognostic factor for colorectal cancer patients with liver - only metastases after hepatectomy, and to explore whether it is superior to the neutrophil - to - lymphocyte ratio (NLR) in predicting disease - free survival (DFS) and overall survival (OS).

Specifically, the researchers analyzed data from 140 patients who underwent hepatectomy after neoadjuvant chemotherapy. They calculated NLR and PLR from preoperative blood cell counts and used the Kaplan - Meier method and multivariate Cox regression method to evaluate the impact of these indicators on DFS and OS. The main purpose of the study was to verify whether PLR could better predict the prognosis of these patients, especially compared with NLR.

The results of the study showed that in univariate analysis, both high NLR and high PLR were associated with lower DFS and OS; however, in multivariate analysis, only PLR remained significant and had a statistically significant impact on DFS and OS respectively. In addition, when patients were divided into three groups according to NLR and PLR, there were significant differences in the 5 - year DFS and OS rates among the groups, further supporting the importance of PLR as a prognostic factor.

In conclusion, this study aimed to explore whether PLR can be used as an independent prognostic factor to predict DFS and OS in colorectal cancer patients with liver - only metastases after hepatectomy, and whether it has more advantages than NLR. The results of the study support the prognostic value of PLR in this specific patient population.